Therefore, FBI-1 promotes the resistance of HCC cells to molecular targeted agents, and knockdown of FBI-1 via its siRNA enhanced the sensitivity of HCC cells to molecular targeted agents. Here, ZBTB7A is linked to hepatocellular carcinoma.